179 related articles for article (PubMed ID: 35644005)
41. The role of bone morphogenetic proteins in endochondral bone formation.
Tsumaki N; Yoshikawa H
Cytokine Growth Factor Rev; 2005 Jun; 16(3):279-85. PubMed ID: 15869898
[TBL] [Abstract][Full Text] [Related]
42. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
[TBL] [Abstract][Full Text] [Related]
43. Autogenous regulation of a network of bone morphogenetic proteins (BMPs) mediates the osteogenic differentiation in murine marrow stromal cells.
Edgar CM; Chakravarthy V; Barnes G; Kakar S; Gerstenfeld LC; Einhorn TA
Bone; 2007 May; 40(5):1389-98. PubMed ID: 17303481
[TBL] [Abstract][Full Text] [Related]
44. Secreted BMP antagonists and their role in cancer and bone metastases.
Todd GM; Gao Z; Hyvönen M; Brazil DP; Ten Dijke P
Bone; 2020 Aug; 137():115455. PubMed ID: 32473315
[TBL] [Abstract][Full Text] [Related]
45. Enhanced Osteogenesis of Adipose-Derived Stem Cells by Regulating Bone Morphogenetic Protein Signaling Antagonists and Agonists.
Fan J; Im CS; Guo M; Cui ZK; Fartash A; Kim S; Patel N; Bezouglaia O; Wu BM; Wang CY; Aghaloo TL; Lee M
Stem Cells Transl Med; 2016 Apr; 5(4):539-51. PubMed ID: 26956209
[TBL] [Abstract][Full Text] [Related]
46. Multiple functions of BMPs in chondrogenesis.
Yoon BS; Lyons KM
J Cell Biochem; 2004 Sep; 93(1):93-103. PubMed ID: 15352166
[TBL] [Abstract][Full Text] [Related]
47. [The role of Smads and related transcription factors in the signal transduction of bone morphogenetic protein inducing bone formation].
Xu XL; Dai KR; Tang TT
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Sep; 17(5):359-62. PubMed ID: 14551929
[TBL] [Abstract][Full Text] [Related]
48. [Signal transduction of BMP/Smad and its relationship with mammalian folliculogenesis].
Wang W; Wang SB; Xu YX
Yi Chuan; 2009 Mar; 31(3):245-54. PubMed ID: 19273436
[TBL] [Abstract][Full Text] [Related]
49. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
Lee CW; Ito K; Ito Y
Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
[TBL] [Abstract][Full Text] [Related]
50. Bone morphogenetic protein-Smad pathway as drug targets for osteoporosis and cancer therapy.
Li B
Endocr Metab Immune Disord Drug Targets; 2008 Sep; 8(3):208-19. PubMed ID: 18782017
[TBL] [Abstract][Full Text] [Related]
51. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.
Nohe A; Hassel S; Ehrlich M; Neubauer F; Sebald W; Henis YI; Knaus P
J Biol Chem; 2002 Feb; 277(7):5330-8. PubMed ID: 11714695
[TBL] [Abstract][Full Text] [Related]
52. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.
Omi M; Kaartinen V; Mishina Y
J Biol Chem; 2019 Nov; 294(47):17818-17836. PubMed ID: 31619522
[TBL] [Abstract][Full Text] [Related]
53. Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years.
Ehata S; Miyazono K
Front Cell Dev Biol; 2022; 10():883523. PubMed ID: 35693928
[TBL] [Abstract][Full Text] [Related]
54. Bone morphogenetic proteins and their antagonists.
Gazzerro E; Canalis E
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):51-65. PubMed ID: 17029022
[TBL] [Abstract][Full Text] [Related]
55. A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs).
Lin Y; Martin J; Gruendler C; Farley J; Meng X; Li BY; Lechleider R; Huff C; Kim RH; Grasser WA; Paralkar V; Wang T
BMC Cell Biol; 2002 Jun; 3():15. PubMed ID: 12097147
[TBL] [Abstract][Full Text] [Related]
56. Bone morphogenetic proteins and their receptor signaling in prostate cancer.
Ye L; Lewis-Russell JM; Kyanaston HG; Jiang WG
Histol Histopathol; 2007 Oct; 22(10):1129-47. PubMed ID: 17616940
[TBL] [Abstract][Full Text] [Related]
57. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
[TBL] [Abstract][Full Text] [Related]
58. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.
Kotzsch A; Nickel J; Seher A; Heinecke K; van Geersdaele L; Herrmann T; Sebald W; Mueller TD
J Biol Chem; 2008 Feb; 283(9):5876-87. PubMed ID: 18160401
[TBL] [Abstract][Full Text] [Related]
59. Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions.
Kloen P; Lauzier D; Hamdy RC
Bone; 2012 Jul; 51(1):59-68. PubMed ID: 22521262
[TBL] [Abstract][Full Text] [Related]
60. Finding partners: how BMPs select their targets.
Blitz IL; Cho KW
Dev Dyn; 2009 Jun; 238(6):1321-31. PubMed ID: 19441058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
